Full Press Release Details
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
AMLX Neutral Sentiment
Amylyx Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
Key Takeaway: Amylyx Pharmaceuticals announced it will report its financial results for the third quarter of 2026 on November 5, 2026. This announcement provides stakeholders with a timeline for upcoming financial disclosures. Further details regarding the results are expected to be shared during the report.
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+173%
120-day peak, hindsight
Typical move
22.5%
average across 4 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
AMX0035
Phase 2 · Wolfram Syndrome
Frequently Asked Questions
When will Amylyx report its Q3 2026 financial results?
Amylyx Pharmaceuticals will report its Q3 2026 financial results on November 5, 2026.
What is the ticker symbol for Amylyx Pharmaceuticals?
The ticker symbol for Amylyx Pharmaceuticals is AMLX.
Where is Amylyx Pharmaceuticals located?
Amylyx Pharmaceuticals is based in Cambridge, Massachusetts.
What type of announcement did Amylyx make?
Amylyx announced the schedule for its Q3 2026 financial results.